Physician profile
Kelsey James
NPI 1720145063
$3,737.87
in general payments reported to CMS, 2019-2025
27 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,705 · 2020: $489 · 2021: $382 · 2022: $244 · 2023: $436 · 2024: $304 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $918.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,180.37 | 2019-2023 | Solyx Sis System |
| Pfizer INC. | $502.43 | 2019-2024 | |
| Coloplast Corp | $409.23 | 2019-2024 | |
| Astellas Pharma US INC | $313.13 | 2020-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $214.60 | 2023-2025 | Gemtesa, Myfembree |
| Abbvie INC. | $213.94 | 2019-2024 | |
| Exeltis, USA INC. | $200.07 | 2022-2025 | Slynd, Nuvessa |
| Therapeuticsmd, INC. | $100.34 | 2019-2020 | |
| Hologic Sales and Service, LLC | $61.48 | 2019-2022 | |
| Ethicon US, LLC | $53.14 | 2019-2021 | |
| Baxter Healthcare | $52.36 | 2019-2024 | Tisseel |
| Exact Sciences Corporation | $50.51 | 2023-2024 | Cologuard Collection Kit |
| Urovant Sciences INC | $48.08 | 2021-2022 | |
| Daiichi Sankyo INC. | $47.26 | 2019-2023 | Injectafer |
| Gynesonics, INC. | $44.41 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $43.55 | 2019-2024 | Prolia, Evenity |
| Axonics, INC. | $27.61 | 2021 | |
| Myovant Sciences INC. | $26.16 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.22 | 2023 | |
| Krystal Biotech INC | $22.52 | 2024 | Vyjuvek |
| Minerva Surgical, INC | $16.88 | 2019 | |
| Meditrina | $15.85 | 2024 | |
| Pharmacosmos Therapeutics INC. | $15.68 | 2021 | |
| Agile Therapeutics, INC. | $14.97 | 2021 | |
| Avion Pharmaceuticals | $14.15 | 2022 | |
| Radius Health, INC. | $12.60 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $12.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.